We learn more about bladder preservation with tri-modality therapy in treatment of bladder cancer. Bladder cancer is the most common malignancy of the urinary system, with an estimated 550 000 new cases worldwide as reported in 20181.  Patients with bladder cancer typically present with gross or microscopic haematuria (blood in urine). Though, symptoms such as a change in urination frequency, urgency, pain or discomfort when urinating, or waking up during the night because you need to urinate frequently may be initial signs of bladder cancer. Risk factors, diagnosis and staging of bladder cancer  Risk factors include exposure to chemical carcinogens, cigarette smoking, chronic…